62,666
edits
Changes
no edit summary
|-
| 2012 || || || Vaccine approval || A quadrivalent inactivated influenza vaccine is licensed in the {{w|United States}}.<ref>{{cite web|title=Influenza|url=https://www.historyofvaccines.org/content/articles/influenza|website=historyofvaccines.org|accessdate=26 April 2018}}</ref> ||
|-
| 2012 || December 12 || {{w|Influenza}} || Vaccine approval || "FDA approved quadrivalent formulation of Fluarix (inactivated influenza vaccine; GlaxoSmithKline)."<ref>{{cite web |title=Quadrivalent flu vaccines coming; companies cite good demand |url=https://www.cidrap.umn.edu/news-perspective/2013/08/quadrivalent-flu-vaccines-coming-companies-cite-good-demand |website=cidrap.umn.edu |accessdate=3 June 2020}}</ref> ||
|-
| 2012 || December 12 || || || "On December 11, 2012, the Institute for Safe Medication Practices (ISMP) issued a press release announcing the launch of its new Vaccine Error Reporting Program. The program allows healthcare professionals to confidentially report vaccine administration errors and near misses. According to the press release, the program's goal is to better quantify sources of errors and advocate for product changes (such as changes to the vaccine name or label) that will ensure patient safety."<ref>{{cite web |title=Issue 1033: January 2, 2013 |url=https://www.immunize.org/express/issue1033.asp |website=immunize.org |accessdate=3 June 2020}}</ref> ||
